Welcome
Solutions
Fragment-based lead generation
Kinetic characterization of inhibitors
Ligand deconstruction studies
Quantitative structure-kinetics modelling and design
Target hopping for kinases
Identification of off-target liabilities for kinase inhibitors
Partners
Working With Us
Research Alliances
Media
News
Events
Publications
Images
About Us
Background
Management
Board
Contact
Management
Per Källblad,
Ph.D.
Chief Executive Officer
Read more »
Helena Danielson,
Prof.
Chief Scientific Officer
Read more »
Latest News
February 3, 2010
-
Dr Gisela Sitbon joins the Board of Beactica
January 29, 2010
-
Beactica welcomes Innovationsbron as a new shareholder
January 13, 2010
-
Professor Bo Öberg joins the Board of Beactica
November 27, 2009
-
Beactica announces its participation in a Marie Curie Initial Training Network
May 26, 2009
-
Beactica announces drug discovery agreement with Cubist Pharmaceuticals
More News »